Clinical Decision Support System to Define 30 Day Adverse Clinical Events for Emergency Department Acute Coronary Syndromes

September 15, 2017 updated by: Serhat Akay, Turkish Ministry of Health Izmir Teaching Hospital

Development of Clinical Decision Support System to Define 30 Day Adverse Clinical Events (Non Fatal Myocardial Infarction, Cardiac Related Death or Coronary Intervention) for Patients Presenting to Emergency Department With Acute Coronary Syndrome

Acute coronary syndromes are among main complains for patients presenting to emergency department. Risk classification systems are used to classify patients to appropriate risks and help physicians manage diagnosis strategies and treatments. Purpose of this study is to develop a clinical decision support system for patients presenting to emergency department with the help of statistical machine learning.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Acute coronary syndromes are among main complains for patients presenting to emergency department and create a burden to emergency departments and hospitals. Risk classification systems were developed and used to classify patients to appropriate risk groups. According to risk classification, different diagnosis and treatment modalities can be used and help physicians manage diagnosis strategies and treatments. Purpose of this study is to develop a clinical decision support system for patients presenting to emergency department with the help of statistical machine learning.

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey
      • Izmir, Turkey, 35000
        • Recruiting
        • Izmir Bozyaka Training and Research Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients presenting to emergency deparmtent with acute chest pain consistent with acute coronary syndrome will be included for analysis.

Description

Inclusion Criteria:

  • Presenting to emergency department with acute chest pain consistent with acute coronary syndrome

Exclusion Criteria:

  • Patients with less than 18 years old
  • Patients presenting with ST-segment elevation myocardial infarction
  • Patients presenting with other causes of acute chest pain (pneumothorax, pulmonary -embolism, aortic dissection
  • Decline to participate in study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients presenting with acute coronary syndrome
Patients presenting to emergency department with acute coronary syndrome
Diagnostic test: Further cardiac imaging
Study patients will be reviewed whether they will have coronary interventions in 30 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non fatal myocardial infarction, cardiac related death or coronary intervention in 30 days
Time Frame: 30 days
Patients will be screened for 30 days for Non fatal myocardial infarction, cardiac related death or coronary intervention (coronary angiogram, coronary artery bypass surgery)
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Turkish Ministry of Health Izmir Teaching Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 12, 2017

Primary Completion (Anticipated)

December 12, 2017

Study Completion (Anticipated)

February 1, 2018

Study Registration Dates

First Submitted

September 15, 2017

First Submitted That Met QC Criteria

September 15, 2017

First Posted (Actual)

September 18, 2017

Study Record Updates

Last Update Posted (Actual)

September 18, 2017

Last Update Submitted That Met QC Criteria

September 15, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TurkishMOHITH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Further cardiac imaging

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe